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Abstract
Background: Modern RNA interference (RNAi) methodologies using small interfering RNA (siRNA) oligonucleotide duplexes
or episomally synthesized hairpin RNA are valuable tools for the analysis of gene function in the protozoan parasite
Entamoeba histolytica. However, these approaches still require time-consuming procedures including transfection and drug
selection, or costly synthetic molecules.
Principal Findings: Here we report an efficient and handy alternative for E. histolytica gene down-regulation
mediated by bacterial double-stranded RNA (dsRNA) targeting parasite genes. The Escherichia coli strain HT115 which
is unable to degrade dsRNA, was genetically engineered to produce high quantities of long dsRNA segments
targeting the genes that encode E. histolytica b-tubulin and virulence factor KERP1. Trophozoites cultured in vitro
were directly fed with dsRNA-expressing bacteria or soaked with purified dsRNA. Both dsRNA delivery methods
resulted in significant reduction of protein expression. In vitro host cell-parasite assays showed that efficient
downregulation of kerp1 gene expression mediated by bacterial dsRNA resulted in significant reduction of parasite
adhesion and lytic capabilities, thus supporting a major role for KERP1 in the pathogenic process. Furthermore,
treatment of trophozoites cultured in microtiter plates, with a repertoire of eighty-five distinct bacterial dsRNA
segments targeting E. histolytica genes with unknown function, led to the identification of three genes potentially
involved in the growth of the parasite.
Conclusions: Our results showed that the use of bacterial dsRNA is a powerful method for the study of gene function in E.
histolytica. This dsRNA delivery method is also technically suitable for the study of a large number of genes, thus opening
interesting perspectives for the identification of novel drug and vaccine targets.
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Introduction
Entamoeba histolytica is a protozoan parasite causing human
amoebiasis, a disease that is a public health problem in endemic
areas [1,2]. Amoebiasis is transmitted by the ingestion of cysts
present in food or water contaminated with feces from amoebic
individuals. The disease is usually asymptomatic; however some
patients develop the symptomatic invasive form leading to
dysentery and liver abscesses that can result in a fatal outcome
without medication [1,2]. The treatment of the disease relies only
in a reduced array of drugs [3]. Recent studies have shown that E.
histolytica cultured in vitro can develop resistance against these
drugs, urging the need for new therapeutic or prophylactic tools to
control this parasitic disease [4]. These developments will not be
possible without a deeper understanding of E. histolytica physiology
and pathogenic process.
Experimental studies on animal models and ex vivo procedures
have so far provided vital insights into the amoebic pathogenic
process [5–11]. However, until now only a few amoebic factors
have been characterized as playing a major role during the
pathogenic process. These include: (i) the Gal/GalNAc-inhibitable
lectin [10,11], (ii) the lysine-rich protein KERP1 [12], (iii) the
cysteine proteinase CP5 [13], (iv) the GPI-anchored surface
components [14] and (v) the lipopeptidophosphoglycans
(EhLPPG) [15,16]. Therefore, further progress is necessary in
the field of amoebiasis towards the establishment of procedures
combining the use of experimental models and molecular tools
capable of knocking down gene expression that would allow more
efficient and systematic studies.
The Entamoeba consortium recently reported the whole genome
of E. histolytica, predicting 8,343 genes [17]. However, a major
drawback for molecular genetics in E. histolytica is that this parasite is
PLoS ONE | www.plosone.org 1 December 2009 | Volume 4 | Issue 12 | e8424not amenable to standard gene-replacement procedures due to an
undetermined genome ploidy and sexual cycle. RNA interference
(RNAi) has recently emerged as a powerful tool to knockdown gene
expression,especiallyineukaryoticorganismsthatarenot amenable
to standard gene-replacement procedures [18,19]. RNAi is a highly
conserved eukaryoticpathway forgene silencingthat is presentfrom
plantstohumans.The pathwayistriggeredbylong double-stranded
RNA (dsRNA) that is cleaved by an endoribonuclease called Dicer
into small interfering RNA (siRNA) oligonucleotides. The resulting
siRNA assemble within endoribonuclease-containing complexes
known as RNA-induced silencing complexes (RISCs) that will
cleave and destroy the cognate RNA.
Although little is known about RNAi machinery in E. hystolytica,
some orthologous proteins have recently been characterized as
sharing similarities with other eukaryotic RNAi factors [20].
Moreover, our group previously reported efficient gene silencing
for E. histolytica trophozoites (vegetative stage of the parasite)
soaked with chemically synthesized siRNA oligonucleotides [21].
Other pioneer reports also showed efficient gene silencing in
trophozoites transformed with plasmid constructs designed for
episomal expression of antisense and short hairpin RNA (shRNA)
[22–24].
Here we explored the feasibility of a direct and cost-effective
approach for the delivery of long dsRNA segments. This method
takes advantage of intrinsic phagocytic properties of E. histolytica,
which naturally feeds on probiotic bacteria present in the intestinal
flora. We showed that trophozoites either directly fed with
dsRNA-expressing bacteria, or soaked with purified dsRNA
resulted in down-regulation of gene expression. In vitro functional
assays showed that downregulation of the virulence factor KERP1
mediated by bacterial dsRNA reduces parasite adhesion to human
cells. Moreover, initial studies using a large repertoire of bacterial
dsRNA targeting amoeba genes led to the identification of three
genes potentially playing a role in the growth of the parasite. Our
observations suggest that genetic interference mediated by
bacterial dsRNA is a convenient approach to conduct large-scale
studies for the analysis of gene function in E. histolytica.
Results
Double-Stranded RNA Bacterial Feeding Targeting E.
histolytica b-Tubulin
Based on E. histolytica phagocytic properties, initial experiments
were conducted to verify whether delivery of bacterial dsRNA
targeting amoeba genes would produce changes in transcript and
protein levels. Initial gene silencing studies were carried out using
E. histolytica b-tubulin (GenBank accession number EHI_049920
or EHI_167010) as a target gene since a highly specific antibody
and quantitative PCR tools were already available in our
laboratory to characterize the outcome of the phenotype (see
Material and Methods).
Escherichia coli strain HT115 was transformed with the plasmid
constructs L4440-beta-tubulin and L4440-GFP that were designed
for the expression of long dsRNA segments (Fig. 1). Bacterial
Figure 1. Genetic interference following ingestion of dsRNA-expressing bacteria by Entamoeba histolytica. A. General scheme for dsRNA
production. The 59-terminal portions of the genes were amplified by PCR and cloned into the bacterial vector L4440 for dsRNA transcription. Primers
used for quantification of mRNA by qRT-PCR match with the 39-terminal part of the gene, which was not cloned into the plasmid (marked ‘‘Q-PCR
template’’ in the figure), allowing the exclusive quantification of genome-encoded, sense-orientated transcripts. The multicloning site of L4440 vector
is bidirectionally flanked by T7 promoters driving the synthesis of RNA complementary strands (i.e. dsRNA). The recombinant plasmid was transfected
into the bacterium HT115, allowing dsRNA purification in order to conduct the parasite soaking experiments or direct feeding of parasites with the
expressing bacteria. B. Constructs performed in this work. Three independent DNA fragments were cloned and used for RNAi experiments including
b-tubulin-, KERP1- and GFP-encoding genes (upper panel). Upon production of dsRNA, a nuclease-resistant dsRNA was detected in lysates of the
recombinant bacterium (bottom panel).
doi:10.1371/journal.pone.0008424.g001
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described [25]. Total bacterial nucleic acids were purified and
treated with DNase and RNaseA to degrade DNA and single-
stranded RNA. Nucleic acid samples were analyzed by agarose gel
electrophoresis (Fig. 1B). A massive smear of dsRNA was observed
with predominant dsRNA bands around the expected sizes for all
transformants except for the untransformed wild-type HT115
bacteria. The variation between the theoretical and observed size
of purified products may be due to the presence of secondary
structures in the RNAs, exposing single-stranded fragments within
the target during digestion, and also affecting migration in gel, as
already commented [25].
Trophozoites cultured under standard in vitro conditions were
fed with bacteria (10
3,1 0
4, and 10
5 bacteria per amoeba)
producing dsRNA. By this setting up, we determined that 10
4
bacteria per amoeba was the optimal dose to observe effects on
growth with b-tubulin targeting. After inoculation of bacteria,
growth was followed for 3, 5 or 7 days (Fig 2A), revealing that
growth was affected in b-tubulin samples from the third day of
culture. In the control condition, i.e. with bacteria expressing gfp
dsRNA, the maximum number of trophozoites was detected as
soon as the third day post-inoculation. Thus, we retained this
condition (inoculum and time) for the following experiments.
Targeting of b-tubulin resulted in a significant reduction of fifty-
eight percent of the endogenous transcript as determined by real-
time PCR. Gene silencing appeared to be highly specific since no
reduction of the b-tubulin transcript was detected in trophozoites
fed with control bacteria carrying dsRNA from the GFP-encoding
gene (Fig. 2B). Reduction of b-tubulin transcript also led to a
qualitative decrease of protein levels, as detected by western blot
analysis using a specific antibody (Fig. 2C).
Targeting of KERP1 Virulence Factor by dsRNA
After observing specific gene silencing of an essential gene such
as b-tubulin, we were interested in determining whether the
phenomenon of RNAi could be inferred for other genes. E. coli
strain HT115 was thus transformed with plasmid construct L4440-
KERP1 that was designed for the expression of dsRNA targeting
E. histolytica virulence factor KERP1 [12] and dsRNA expression
was verified as described above (Fig. 1). Trophozoites cultured in
vitro were fed with dsRNA-expressing bacteria targeting KERP1
using a ratio of 10
4 bacteria per amoeba. After two days of
bacterial feeding, trophozoite crude extracts and mRNA samples
were prepared to characterize the gene expression profile. A
representative western blot is shown in Figure 3A; together with
two other independent experiments, it allowed an evaluation of
protein abundance by semi-quantitative densitometry analysis of
scanned films. An average decrease of forty-eight percent of
protein was determined, although no significant reduction of
endogenous transcript was observed. Trophozoites fed with gfp
dsRNA-expressing bacteria showed higher growth rates at day one
compared to the wild-type control (p=0.032; Fig. 3B). Neverthe-
Figure 2. Targeting b-tubulin-encoding gene by dsRNA expressed in bacteria. Following 3, 5 and 7 days of culture of 3610
5 E. histolytica
trophozoites in the presence of bacteria expressing dsRNA from genes encoding GFP (control) or b-tubulin (test), the parasites were counted under
the microscope(A). At day 3 post-inoculation, endogenous mRNA was quantified by qRT-PCR (B) and protein levels were observed by western blot (C)
according to procedures described in the materials and methods. Each graph represents the mean of 3 independent experiments.
doi:10.1371/journal.pone.0008424.g002
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variation in trophozoite number between the three tested
conditions. To reduce the possible sources of variation impacting
the reproducibility of the experiment, trophozoites were directly
soaked with purified dsRNA.
The gene expression profile was also characterized as above for
trophozoites soaked with different concentrations of purified
bacterial dsRNA targeting KERP1. A thirty-four percent reduction
of protein was observed by using 50 mg of purified kerp1 dsRNA per
mL of culture media (Fig. 3C), whereas incubation with 5 mg/ml
and 25 mg/ml kerp1 dsRNA did not trigger a sensible reduction of
KERP1 abundance (data not shown). Moreover, dsRNA soaking
resulted in a consistent reduction of kerp1 transcript as opposed to
the feeding method (Fig. 3C). Growth rate identical to untreated
cells (Fig. 3D) was also observed.
In vitro parasite–human cell interaction assays were carried out
to support the effectiveness of gene silencing mediated by bacterial
dsRNA. According to the possible interference of bacteria in
adherence assays, we chose to use exclusively the soaking method
to perform the following experiments. Trophozoites that were
previously soaked with kerp1 dsRNA during forty-eight hours,
adhered significantly less (0.5960.37 relative units [r.u]) to fixed
human liver sinusoidal cells (LSECs) compared to untreated
trophozoites (WT; 1.0060.24 r.u., p=1.46610
23) or trophozoites
soaked with gfp dsRNA (GFP: 0.7760.43 r.u., p=2.47610
22), as
presented in Figure 4A. In addition, trophozoites soaked with kerp1
Figure 3. Phenotype of trophozoites fed with bacteria producing kerp1 dsRNA or soaked in medium containing kerp1 dsRNA.
Experiments were performed with trophozoites incubated without (wild type, ‘‘WT’’), with bacteria producing gfp or kerp1 dsRNAs or with purified
dsRNA (50 mg/ml) for the indicated times. A and C. Upper frames: Western blot analysis of KERP1 protein abundance after 2-day incubation. Actin
immunodetection confirms that equal numbers of amoebae were loaded in each well. Lower frames: Quantification of kerp1 gene mRNA expression
and protein abundance within trophozoites after feeding for 2 days. Quantitative PCRs were normalized by quantifying the mRNA coding for L9
ribosomal protein. Western blots were normalized using immunodetection of actin. For both methods, relative quantification of the samples was
achieved by linear regression using dilutions of samples as standards. Data were calculated from 3 independent experiments. B and D. Analysis of
parasite growth. Tubes were inoculated with 2610
4 trophozoites and 2610
7 bacteria, when applicable. After 1 to 3 days of interaction, amoebae
were harvested and counted with a hemocytometer. Data were calculated from 3 independent experiments (n=3).
doi:10.1371/journal.pone.0008424.g003
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monolayers compared to controls (kerp1 dsRNA: 0.7660.10 r.u.;
WT: 1.0060.03 r.u., p=2.47610
24; GFP: 1.0460.15 r.u.,
p=4.28610
24; Fig. 4B).
Identification of Genes Potentially Implicated in the
Growth of E. histolytica
We explored the use of dsRNA for gene expression interference
for a random identification of genes whose inactivation can be
essential for developmental phenotype of trophozoites cultured
under axenic conditions. To this goal, we prepared a cDNA library
(in L4440 plasmid vector, using HT115 bacterial strain), sequenced
the bacterial clone inserts and compared the data to the E.
histolytica annotated genome by BLAST. A repertoire of 408 distinct
amoebic DNA sequences was obtained, with 256 of them
corresponding to unique genes. Eighty-five ORFs encoding
potential proteins of unknown function (Table 1) were identified
and assessed for dsRNA gene silencing. Trophozoites cultured in
96-well microtiter plates were individually treated with fractions of
distinct dsRNA species that were purified from bacterial microtiter
plate inductions. After twenty-four and forty-eight hours of
treatment with purified dsRNA fractions, light micrographs from
microtiter plate wells were obtained for the identification of clones
potentially leading to a reduction or inhibition of trophozoite
growth compared to untreated or gfp dsRNA control conditions.
Five dsRNA fractions targeting amoebic genes resulted in
microscope visible reduction of trophozoite numbers (data not
shown); the corresponding bacterial clones were called C3, D7, G1,
G5 and G7. The feeding method was used to further characterize
the growthphenotypes ofthese fiveclones. Trophozoitescultured in
standard culture tubes were individually fed with bacteria
expressing the dsRNA species from the clones. A significant delay
in trophozoite growth at 24 hours was confirmed with bacterial
clones expressing dsRNA targeting annotated genes EHI_176840
(clone D7) and EHI_148060 (clone G5; Fig. 5B and Table 2) and at
48 hourswith EHI_053430 (cloneC3)and EHI_148060 (clone G5).
In silico analysis of these three currently uncharacterized target
genes, showed that EHI_176840 encoded a protein containing a
ribonucleotide-binding domain characteristic of Ribonucleases II
(RNP), EHI_148060 encoded a protein containing a transmem-
brane domain (DUF850) and EHI_053430 has a domain
homologous to ubiquitin. Utilizing a t-paired statistical test showed
that the clone G7, expressing dsRNA targeting EHI_178560
(carrying a lipid-binding domain), was not significant although a
Figure 4. Study of KERP1 involvement in trophozoite interaction with LSECs. A. Assay for adherence of modified trophozoites to LSECs.
Quantification of trophozoites bound to LSECs after 30 min contact showed 50% decrease in adherence of KERP1-reduced trophozoites. Data were
calculated from 3 independent experiments (n=3). B. Assay for cytopathogenicity of modified trophozoites on LSECs. Quantification of fluorescence
emitted by LSECs after 1 hr incubation with trophozoites showed a decreased cytopathogenicity of KERP1-reduced trophozoites leading to 24%
reduction in fluorescence. Data obtained from 3 independent experiments (n=3).
doi:10.1371/journal.pone.0008424.g004
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Library Clone Gene ID* Match % length bp Mis match Gap Start gene End gene E Value Score
ehcs0010A05.b EHI_194230 100 316 0 0 750 435 3E-142 502
ehcs0010A13.b EHI_079850 100 363 0 0 1 363 2E-161 565
ehcs0010A23.b EHI_048560 100 266 0 0 8 273 9E-119 423
ehcs0010B04.b EHI_159490 100 165 0 0 1 165 1E-70 263
ehcs0010B11.b EHI_012120 99,15 704 5 1 12 715 0 1090
ehcs0010B18b EHI_010710 100 175 0 0 792 966 1E-75 278
ehcs0010B23.b EHI_023620 100 131 0 0 1558 1428 1E-54 209
ehcs0010C19.b EHI_153280 100 75 0 0 581 655 4E-22 101
ehcs0010C22.b EHI_156420 98,49 730 8 2 56 785 0 1012
ehcs0010D11.b EHI_147520 100 296 0 0 84 379 3E-129 458
ehcs0010D15.b EHI_007620 100 170 0 0 179 10 3E-73 271
ehcs0010D17.b EHI_189900 100 259 0 0 1272 1530 5E-115 412
ehcs0010E16.b EHI_044370 100 294 0 0 1891 1598 5E-132 467
ehcs0010E24.b EHI_153520 100 133 0 0 60 192 6E-29 123
ehcs0010F11.b EHI_021360 100 480 0 0 9 488 0 762
ehcs0010F23.b EHI_159750 100 183 0 0 555 737 2E-79 291
ehcs0010G03.b EHI_138770 100 296 0 0 1 296 5E-112 400
ehcs0010G15.b EHI_136410 100 661 0 0 1 661 0 1036
ehcs0010H14.b EHI_060360 99,71 689 2 0 374 1062 0 1015
ehcs0010H15.b EHI_119930 100 333 0 0 2013 1681 1E-150 529
ehcs0010H21.b EHI_053430 99,49 588 3 0 39 626 0 871
ehcs0010H23.b EHI_001130 100 109 0 0 1279 1387 9E-25 109
ehcs0010I11.b EHI_014250 100 386 0 0 206 591 4E-96 348
ehcs0010I16.b EHI_024460 99,55 224 1 0 2004 1781 3E-98 355
ehcs0010I17.b EHI_030450 100 624 0 0 2102 1479 0 811
ehcs0010I22.b EHI_026400 100 473 0 0 1171 699 0 751
ehcs0010J01.b EHI_146390 100 104 0 0 6 109 2E-12 68,2
ehcs0010J12.b EHI_186830 100 157 0 0 186 30 5E-67 250
ehcs0010J14.b EHI_107270 100 579 0 0 5 583 0 908
ehcs0010J20.b EHI_166860 100 320 0 0 333 14 2E-144 508
ehcs0010K07.b EHI_158130 99,7 335 0 1 356 23 5E-110 394
ehcs0010K16.b EHI_012280 100 673 0 0 676 4 0 801
ehcs0010K17.b EHI_141940 100 387 0 0 22 408 3E-176 614
ehcs0010K19.b EHI_146110 98,98 683 7 0 986 304 0 1061
ehcs0010K23.b EHI_010570 99,86 697 1 0 20 716 0 1103
ehcs0010L01.b EHI_063570 100 306 0 0 7 312 9E-138 486
ehcs0010L05.b EHI_045540 100 388 0 0 434 47 9E-177 616
ehcs0010L10.b EHI_148060 100 334 0 0 461 794 4E-151 530
ehcs0010L20.b EHI_125630 100 408 0 0 4 411 0 635
ehcs0010L21.b EHI_049670 100 58 0 0 2401 2458 2E-19 93,5
ehcs0010L24.b EHI_050800 100 192 0 0 1704 1513 2E-83 305
ehcs0010M11.b EHI_113930 100 84 0 0 1 84 4E-32 134
ehcs0010N05.b EHI_198680 100 328 0 0 488 161 2E-131 465
ehcs0010N11.b EHI_042710 100 162 0 0 515 676 2E-69 258
ehcs0010N13.b EHI_176840 100 440 0 0 914 475 0 698
ehcs0010P06.b EHI_163530 100 195 0 0 224 418 1E-81 299
ehcs0010P24.b EHI_105350 100 358 0 0 30 387 2E-162 569
ehcs0011E13.b EHI_042930 100 169 0 0 169 1 1E-72 269
ehcs0011F01.b EHI_197560 100 137 0 0 163 27 3E-53 204
ehcs0011H03.b EHI_148780 100 143 0 0 1676 1818 2E-60 228
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RNAi treatment. The target gene knockdown shown by these data
suggest that dsRNA induces downregulation of amoebic gene
expression whether dsRNA was delivered by feeding of bacteria or
by soaking parasites in purified dsRNA.
Discussion
The data shown in the present report indicates that the use of
bacterially-expressed dsRNA efficiently reduces gene expression in
the protozoan parasite E. histolytica. This method is specific,
affecting only the expression of the gene targeted whether the
dsRNA was delivered via bacterial feeding or medium soaking.
Our approach was mostly inspired by the RNAi approach
established by the group of Dr. Andrew Fire in the nematode
Caenorhabditis elegans [25] and also in RNAi studies with planarian
fatworms [26]. Introduction of dsRNA into cells can be obtained
by soaking these worms in solutions of dsRNA or feeding them
with bacteria expressing dsRNA. The machinery allowing dsRNA
degradation is subsequently triggered as a potent cell response
where proteins binding dsRNA are central to induce the RNA
interference (RNAi) phenomenon. During feeding, E. histolytica
uses its capacities to phagocytise bacteria, although the mode of
dsRNA delivery into the cytoplasm from the phagosomes is
unknown. During soaking, dsRNAs enter into the amoeba by an
unknown mechanism; potentially either by endocytic processes or
by receptor- or transporter-mediated RNA entry. Identification of
receptors or transporters for dsRNAs in E. histolytica would provide
Library Clone Gene ID* Match % length bp Mis match Gap Start gene End gene E Value Score
ehcs0011K14.b EHI_104440 100 66 0 0 1147 1212 4E-24 106
ehcs0011M17.b EHI_048730 100 70 0 0 16 85 5E-26 112
ehcs0011O04.b EHI_001800 100 79 0 0 56 134 3E-30 126
ehcs0011A08.b EHI_178560 100 643 0 0 647 5 0 1009
ehcs0011A12.b EHI_054480 100 209 0 0 8 216 1E-91 332
ehcs0011A16.b EHI_169840 100 391 0 0 17 407 3E-178 621
ehcs0011A22.b EHI_105770 100 218 0 0 12 229 6E-96 347
ehcs0011B11.b EHI_050960 100 416 0 0 21 436 8E-165 576
ehcs0011D07.b EHI_087410 97,6 250 3 2 263 17 6E-85 310
ehcs0011D09.b EHI_048670 100 228 0 0 711 484 2E-93 339
ehcs0011D11.b EHI_111070 100 281 0 0 300 20 7E-126 446
ehcs0011D17.b EHI_010510 99,69 646 2 0 784 139 0 917
ehcs0011E03.b EHI_109690 99,51 615 3 0 865 251 0 971
ehcs0011E09.b EHI_029030 100 204 0 0 230 27 3E-89 324
ehcs0011E10.b EHI_182730 100 211 0 0 34 244 1E-92 336
ehcs0011E11.b EHI_188850 100 637 0 0 9 645 0 898
ehcs0011E14.b EHI_117850 100 276 0 0 436 161 2E-123 439
ehcs0011E23.b EHI_136350 99,57 234 1 0 162 395 1E-102 369
ehcs0011F05.b EHI_086230 100 266 0 0 29 294 2E-104 375
ehcs0011G15.b EHI_092080 99,52 210 1 0 1367 1158 5E-61 232
ehcs0011G20.b EHI_048420 99,73 374 1 0 385 12 8E-166 580
ehcs0011H07.b EHI_042690 100 236 0 0 258 23 2E-104 375
ehcs0011I06.b EHI_046260 98,16 326 0 1 1011 1336 5E-132 467
ehcs0011I10.b EHI_188720 99,5 604 3 0 8 611 0 928
ehcs0011I19.b EHI_066760 100 210 0 0 1 210 4E-92 334
ehcs0011K13.b EHI_047800 100 579 0 0 628 50 0 919
ehcs0011L01.b EHI_169620 97,66 128 3 0 131 4 4E-50 194
ehcs0011M02.b EHI_010050 100 433 0 0 1518 1950 0 687
ehcs0011M23.b EHI_000140 100 297 0 0 6 302 2E-133 472
ehcs0011O15.b EHI_070680 99,86 697 1 0 1303 607 0 1093
ehcs0011O21.b EHI_035670 100 198 0 0 392 195 2E-86 315
ehcs0012A01.b EHI_008820 100 364 0 0 519 156 2E-161 565
ehcs0012A10.b EHI_131130 99,84 626 1 0 1173 548 0 992
ehcs0012B10.b EHI_184010 100 158 0 0 1226 1383 2E-67 252
ehcs0012C01.b EHI_076270 100 157 0 0 701 545 5E-23 104
Gene ID et http://pathema.jcvi.org/ found by BLAST search.
doi:10.1371/journal.pone.0008424.t001
Table 1. Cont.
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and targeted gene expression modification by exogenous genetic
material, as it was initially shown in Caenorhabditis elegans [27].
Whatever the dsRNA entry mechanism involved, we have shown
that robust and reproducible RNAi phenotypes can be produced
in E. histolytica upon contact with dsRNA synthesized in bacteria.
The availability of E. histolytica genome allowed searching for
orthologous genes containing the hallmark factors of the RNAi
cascade. Surprisingly, no orthologous gene was found for the
RNaseIII-family enzyme Dicer that catalyzes the cleavage of
dsRNA segments into siRNA duplexes that are loaded onto the
RNA-induced silencing complex (RISC) by the Argonaute
component also responsible for cleaving target mRNA [28].
Nevertheless, an RNaseIII-like protein of E. histolytica was recently
characterized and shown to use dsRNA as a substrate [20].
Moreover, other genes encoding orthologues of RdRP [29] and
Argonaute [20] have also been reported to exist in E. histolytica.
Our group was the first to show that siRNA oligonucleotide
duplexes induce specific gene silencing in E. histolytica, providing
experimental evidence supporting the existence of an RNAi
pathway in this parasite [21]. This is also consistent with other
gene silencing studies for E. histolytica using episomally-expressed
anti-sense and shRNA [22,23]. Nevertheless, technical disadvan-
tages related to the former methods encouraged us to standardize
a method that could be used systematically for a large number of
targets. The feeding method with dsRNA expressing bacteria used
for this work, took advantage of the phagocytic capabilities of E.
histolytica. Interestingly, this method was shown to be a direct and
cost-effective way to downregulate the housekeeping gene b-
tubulin (Fig. 2). These initial observations using bacterial feeding
encouraged us to target other E. histolytica genes.
The E. histolytica virulence factor KERP1 [12,30] that was
previously characterized as a tightly regulated gene, was an
interesting and challenging target to further assess the effectiveness
of gene silencing mediated by bacterial dsRNA. A moderate but
significant reduction of KERP1 protein abundance was found
using bacterial feeding, however, no significant kerp1 transcript
reduction was observed. This observation correlates with our
previous results, showing that kerp1 anti-sense RNA transcription
in E. histolytica does not lead to a reduction of the full-length,
endogenous mRNA abundance, unless amoebae are stressed [12].
The inhibitory effect of dsRNA was also verified in another
series of experiments using soaking as a delivery method. A more
consistent transcript and protein downregulation was found with
soaking even though the amount of purified dsRNA that was used
was similar to unpurified bacterial dosage used in the feeding
experiments. Differences in the entry of dsRNA might account for
the better efficacy of dsRNA soaking. These results are consistent
with other RNAi studies comparing the use of feeding and soaking
as delivery methods in parasites [31]. Another advantage using the
medium soaking was that no changes in the growth behaviour of
the trophozoites were observed using unrelated dsRNA, probably
due to conditions bypassing the presence of unspecific bacterial
material and bacteriostatic drugs used for the feeding. The
experimental conditions established so far for the inhibitory effects
of dsRNA allowed us to confirm for the first time in vitro the
previously proposed role of the virulence factor KERP1 [30]. The
inhibition of KERP1 by soaking showed its involvement in
parasite adhesion to human cells and concomitant cytopathogenic
capabilities. Moreover, RNAi conditions were also useful for the
screening of growth-related factors. Potentially interesting genes
were for the first time described, opening alternatives for studies on
the phenomenon of lipid–cell transfer and RNA degradation of
ubiquitination in this parasite.
At this point, the molecular mechanism providing effectiveness
of RNAi in E. histolytica is not known; however, the methods we
describe here are feasible, affordable and therefore should provide
greater general utility than previously published methods. Both
Table 2. Bioinformatic search for hypothetical protein domains targeted by dsRNA interference.
CLONE GENE ID (Pathema) ORF (bp) FRAGMENT (bp) DOMAIN (amino acids) * E-value
C3 EHI_053430 771 21–682 UBQ (185–255) 4.67e-01
D7 EHI_176840 1371 468–913 RNB (174–420) 4.70e-05
G1 EHI_044370 2046 1598–1892 Signal peptide (1–20)
SGA1 (301– 681) 4.00e-17
G5 EHI_148060 822 461–799 DUF850 (9–246) 9.40e-43
G7 EHI_178560 681 5–648 START (5–199) 6.40e-04
*Protein domains were identified by SMART search (http://smart.embl-heidelberg.de/).
UBQ: Ubiquitin homology; RNB: Catalytic domain of ribonuclease II;
SGA1: Glucoamylase and related glycosyl hydrolases;
DUF 850: This family consists of eukaryotic putative transmembrane proteins of unknown function; START: a lipid-binding domain
doi:10.1371/journal.pone.0008424.t002
Figure 5. Selection of candidate genes for potential role in
growth defects in E. histolytica by feeding experiments.
Quantification of trophozoite growth was performed at 24 and 48 hrs
during the feeding experiment with the C3, D7, G1, G5 and G7,
previously selected from a visual screening of trophozoites soaked with
85 target genes. Results are the mean of 3 independent experiments
(n=3).
doi:10.1371/journal.pone.0008424.g005
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advantages. The soaking method is highly reproducible, does not
require antibiotics, phagocytosis or the presence of unspecific
bacterial material. The feeding method is fast, inexpensive and
easy to perform; we already built a library available for the
scientific community, allowing immediate and cost-effective
experiments and screenings. These methods will improve gene
knockdown studies that, in combination with recent developments
in instrumentation and image analysis, should enable the use of
high-throughput screening approaches to elucidate the pathogenic
capabilities of E. histolytica.
Materials and Methods
Bacterial Strain, Cells and Culture Conditions
RNAseIII-deficient Escherichia coli strain HT115 (rnc14::DTn10)
[32] was grown in LB broth for genetic engineering procedures or
2YT broth for the expression of dsRNA, both containing
antibiotics ampicillin (100 mg/ml) and tetracycline (10 mg/ml).
The pathogenic E. histolytica strain HM1:IMSS was cultured
axenically in TYI-S-33 media at 37uC, as previously described
[33].
For the bacterial feeding experiments, E. histolytica trophozoites
were cultured in F-TYI-S-33 medium (TYI-S-33 supplemented
with 34 mg/ml chloramphenicol, 100 mg/ml ampicillin and
10 mg/ml tetracycline).
For growth kinetics in culture tubes, adherent trophozoites were
detached at indicated time with ice-cold incubation for 5 min and
cells were counted using a Malassez slide and trypan blue
exclusion.
Human liver sinusoid endothelial cells (LSEC) were cultured in
RPMI-glutamax medium (Gibco BRL) supplemented with 10%
heat-inactivated fetal calf serum, 100 U/ml penicillin and 100 g/
ml streptomycin, at 37.5uC in a 5% CO2 incubator, as previously
described [34].
Plasmid Constructs for the Expression of dsRNA
For the construction of dsRNA-expression vectors, DNA
fragments at the 59 end of the E. histolytica genes (753 bp for
beta-tubulin, GenBank accession nu: EHI_049920; 388 bp for
KERP1, GenBank accession nu: EHI_098210) and green
fluorescent protein (GFP) full coding sequence (GenBank accession
nu: U73901) were amplified by PCR using specific primers (see
Table S1) and subcloned into the TA-cloning vector pCR2.1-
TOPO (Invitrogen). DNA inserts were excised from TA-cloning
constructs with restriction enzymes (KpnI and BamHI for beta-
tubulin and GFP and; EcoRI for KERP1) and cloned into the
MCS of L4440 plasmid vector [25] that is bidirectionally flanked
by T7 promoters. The resulting plasmid constructs L4440-beta-
tubulin, L4440-KERP1 and L4440-GFP were verified by
restriction analysis and DNA sequencing.
Bacterial Transformation and Expression of dsRNA
HT115 competent cells for bacterial transformation were
prepared by the rubidium chloride method [35]. Competent cells
were transformed with recombinant plasmid DNA by heat shock
pulse at 42uC for 60 sec. After recovery on LB media at 37uC for
1 hr, cells were spread on LB-agar plates containing ampicillin-
tetracycline. Isolated bacterial colonies were obtained after
overnight culture at 37uC.
Bacterial expression of individual dsRNA species was carried
out in standard culture flasks filled with 1/10 of total capacity,
incubated at 37uC with shaking at 220 rpm or in static 96 deep
well plates (Axygen) filled with 1.5 ml of culture broth and
sealed with breathable sealing film. Overnight bacterial cultures
of isolated colonies were diluted 1/50 in 2YT broth supple-
mented with ampicillin/tetracycline and cultured at 37uCt oa n
optical density of 0.6 at 600 nm, (,5 hr with shaking or 36 hr
for static deep well plate culture). Supplementary ampicillin/
tetracycline was added as above and bidirectional transcription
of complementary RNA strands was induced with 2 mM IPTG
during 4 hr at 37uC with shaking or overnight for deep well
plates.
Trophozoite Feeding with dsRNA-Expressing Bacteria
Glass culture tubes or plastic flasks containing F-TYI-S-33 were
inoculated with trophozoites freshly collected from ,90%
confluent culture to obtain a final density of 2 to 3.5610
4 cells
(as indicated for each experiment) per 14-ml tube for growth
kinetic assays or a ,10% confluence (10
5 amoebae) for other
experiments, and incubated at least 1 hr at 37uC before bacterial
feeding. For each condition, a bacterial inoculum prepared in F-
TYI-S-33 was added to the trophozoite culture to obtain a final
ratio of 10
4 bacteria per amoeba. Cellular density of bacterial
inoculums was determined assuming that an optical density of 1 at
600 nm corresponds to 10
8 bacteria/ml. Trophozoites fed only
once with dsRNA-expressing bacteria were incubated at 37uC
during indicated time of culture.
Statistical Analysis
Mean values from experimental replicates were analyzed by
using a paired t-test to determine between-groups significance. * p-
values ,0.05 were considered significant; ** stands for p-values ,
0.01, *** for p-values ,0.001.
Purification of Bacterial dsRNA
Fractions of bacterially-expressed dsRNA species were
prepared using a protocol that was adapted for large-scale
purification (12–20 mg/ml of induction) or 96 well microtiter
plate purification (V-shape wells, Nunc) [25]. For each
bacterial clone, cells were induced for the expression of
dsRNA and bacterial pellet was resuspended in 1 M
ammonium acetate, 10 mM EDTA to 1/20 of initial induction
v o l u m e .A f t e ra d d i n gt h es a m ev o l u m eo fp h e n o l : c h l o r o f o r m
:isoamyl alcohol (25:24:1) pH 8.0, samples were mixed,
incubation at 65uC for 15 min and centrifuged at 10,000 g
for 15 min (for plates: 3,200 g for 30 min). The upper phase
was transferred to fresh tubes or wells and mixed with equal
volume of isopropanol, incubated 30 min at 220uC, then
centrifuged at 12,000 g for 30 min (for plates: 3,200 g for 2 hr).
Nucleic acid pellet was washed with 70% ethanol, air-dried,
then resuspended in 1/100 of initial induction volume with
boiling nuclease-free water, then supplemented with Turbo
DNase buffer (Ambion) and incubated 30 min at room
temperature. Nucleic acid solution was treated with 0.4 U/ml
of Turbo DNase and 0.2 mg/ml of RNase A (Ambion) at 37uC
for 1 hr. After adding 1 volume of phenol:chloroform:isoamyl
alcohol, samples were mixed and centrifuged at 12,000 g for
15 min (for plates: 3,200 g f o r3 0 m i n ) .U p p e rp h a s ew a s
collected, mixed with 0.5 volume of 7.5 M ammonium acetate
and 1 volume of isopropanol, and then centrifuged at 12,000 g
for 30 min. Each pellet was washed twice with 70% ethanol,
air-dried and resuspended in 1X TE. Samples were incubated
for 1 min at 90uC and cooled down at room temperature for
30 min. Double-stranded RNA fractions were analyzed by
agarose gel electrophoresis and concentration determined by
spectrophotometry.
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Trophozoites that were seeded in culture flasks or tubes using an
initial density identical to the feeding experiments were treated
with purified fractions of bacterial dsRNA species that were
directly added into culture media to a final concentration of 5, 25
and 50 mg/ml. Soaked trophozoites were incubated at 37uC
during indicated time of culture.
Quantitative Real-Time PCR
Trophozoite RNA was purified by using TRIzol method
(Invitrogen) as previously described [12]. After primer-specific
reverse transcription, qRT-PCR was performed (primers present-
ed in Table S1) and analyzed according to a published method
[12]. Three independent biological samples were analyzed (n=3);
for each of them, data from two 10-fold dilutions of DNA matrix,
each repeated in triplicates, were averaged.
Antibodies
A rabbit anti-beta-tubulin polyclonal antibody was obtained
from Eurogentec (Belgium) by immunization with two synthetic
peptides with sequences derived from the amino acid sequence of
E. histolytica beta-tubulin (amino acids 50 to 64: FSESSTK-
RYVPRSIN; and amino acids 324 to 338: DVEEQLYKIR-
EKNPD). Immunoglobulin fraction from polyclonal serum was
purified using protein G affinity chromatography (GE Healthcare
Bio-Sciences) and the specificity was verified by western blot
analysis using recombinant fractions of E. histolytica alpha, beta and
gamma tubulin (not shown). An anti-KERP1 monoclonal
antibody used for this work was obtained as described elsewhere
[12].
For western blotting analysis, the amount of proteins was
normalized using an anti-actin C4 monoclonal antibody and
secondary HRP-antibodies (MP Biomedicals) as previously
described [12].
Western Blot Analysis
Trophozoites from feeding or soaking experiments were
collected to prepare crude extracts using a protease inhibitor
cocktail (Roche) as previously described [12]. Crude extracts (10
4
cells/lane) and a calibration curve of different protein amounts of
the reference sample were resolved by SDS-PAGE. Electropho-
resed proteins were transferred to nitrocellulose membranes and
probed with specific antibodies and ECL Plus reagent (GE
Healthcare Bio-sciences) for chemiluminescence detection [12].
Semi-quantitative analysis of light emission from probed nitrocel-
lulose membranes was carried out using Gel doc apparatus and
Quantity one software (BioRad).
Cell Adhesion Assays
Adhesion of trophozoites to human liver sinusoid endothelial
cells (LSEC) was determined using fluorescent micrographs and
image analysis from in vitro assays performed in flat-bottom 24-
well microtiter plates (TTP) [36]. Briefly, trophozoites previously
treated with purified dsRNA and untreated trophozoites, were
stained with 2.5 mM Cell Tracker Orange CMTMR (Invitrogen)
at 37uC for 30 min and inoculated in triplicate to a final density of
10
5 parasites/well together with formaldehyde-fixed LSEC
monolayers, as previously described [36]. After 30 min at 37uC
in 5% CO2, wells were washed with warm phosphate buffer saline
(PBS) at 37uC and fixed with 5% formaldehyde for 30 min, then
washed again. Micrographs from microtiter plate wells (9 fields per
well) were obtained using confocal apotome microscopy (Zeiss)
and trophozoites were manually counted using ImageJ software’s
plug-in ‘‘cell counter’’ (http://rsb.info.nih.gov/ij). The experiment
was repeated thrice; the results from the triplicates on each plate
were pooled and expressed as relative adhesion index using the
following formula [(mean number of adherent trophozoites) /
(mean number of adherent trophozoites in the untreated
conditions from the 3 experiment repetitions)].
Cytophatogenicity Assays
Trophozoite cell cytopathogenic activity was tested against
LSECs as target cells, using a fluorescence assay that was modified
from previously described method [36]. The assay was performed
in flat-bottom 24-well microtiter plates (TTP). Trophozoites
previously treated with purified dsRNA and untreated trophozo-
ites, were seeded in triplicate to a final density of 10
5 parasites/well
together with BCECF-labeled LSEC monolayers [37]. After 1 hr
at 37uCi n5 %C O 2, culture media supernatant was removed,
wells washed twice with warm PBS at 37uC and fresh media was
added. The fluorescence was read for all of the wells directly by the
Fluoroskan Ascent (Thermo Scientific) at excitation/emission
wavelengths of 485/538 nm. Fluorescence data was used to
calculate raw cytopathogenicity rate according to the formula
[(background fluorescence – test fluorescence) / (background
fluorescence – maximum cytopathogenicity)]. Background fluo-
rescence represents fluorescence from LSECs in medium alone,
and maximum cytopathogenicity is the fluorescence from LSECs
totally lysed in medium plus 1% Triton X-100, each measured in
three replicate wells. The experiment was repeated thrice; the
results of the triplicates were averaged and expressed as the index
of cytopathogenicity, from the formula [(raw cytopathogenicity
rate) / (raw cytopathogenicity rate in untreated conditions from
the 3 experiment repetitions)].
Repertoire of dsRNA Expressing Clones
Synthesis of double-stranded cDNA from E. histolytica poly(A)-
mRNA was carried out using oligo-(dT) primer, Superscript II
Retro-Transcriptase and DNA polymerase I (Ambion). Fragments
of cDNA higher than 300 bp were purified by size-exclusion
chromatography column, phosphorylated and ligated to EcoRV-
digested and dephosphorylated L4440 plasmid vector. HT115
competent cells were transformed with ligation reaction as
described above. Individual colonies from bacterial transformation
were transferred from LB-agar plates to microtiter plate wells
containing LB broth - ampicillin/tetracycline using an automated
system (TECAN Genesis workstation), and grown overnight at
37uC for in plate plasmid DNA purification and sequencing
analysis. Full sequence of plasmid inserts from one thousand
bacterial clones was analyzed in silico (using BLAST programme)
and a list of 408 bacterial clones carrying amoebic coding
sequences was obtained. All cDNA sequencing data and blast
results were deposited at GeneBank (http://www.ncbi.nlm.nih.
gov/Genbank/index.html) with the accession number GT128032
to GT128439. Among positive clones, a repertoire of 85 clones
carrying distinct coding sequences for hypothetical proteins of
unknown function was selected for the 96-well microtiter plate
purification of dsRNA and growth phenotype screening (Table 1).
Microtiter Plate Screen
A high-throughput screening for trophozoite growth phenotype
after treatment with distinct species of dsRNA directly soaked in
culture media supernatant was carried out in flat-bottom 96-well
microtiter plates (Greiner Bio-One). Trophozoites freshly collected
were seeded in plate wells to a final density of 600 parasites/well
[38]. After 1 hr at 37uC in a Genbag anaer (BioMe ´rieux), plate
wells were individually soaked with a repertoire of 85 distinct
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,1 mg of dsRNA per well in 20 ml. After 24 and 48 hr of culture,
light micrographs from microtiter plate wells were obtained for
the identification of wells showing a reduction of trophozoite
numbers, using as a reference untreated or GFP-dsRNA treated
trophozoites.
Supporting Information
Table S1 Oligonucleotide primers for cloning and qRT-PCR.
Found at: doi:10.1371/journal.pone.0008424.s001 (0.03 MB
XLS)
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